This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chong Kun Dang Pharmaceutical Corporation. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovations in Oncology: The Contributions of Inventor Kyung-Joo Lee
Introduction
Kyung-Joo Lee, an inventive mind based in Cheonan-si, South Korea, has made significant contributions to the field of pharmaceutical innovations. As a dedicated researcher at Chong Kun Dang Pharmaceutical Corporation, Lee has been at the forefront of developing novel therapeutic agents aimed at combating malignant tumors.
Latest Patents
One of Lee's notable innovations is the patent titled "Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same." This invention highlights a thiazole-containing benzophenone derivative designed to inhibit microtubule formation, which is crucial for the proliferation of cells. The patent discloses not only the chemical structure and various forms of the derivative but also its pharmaceutical applications aimed at treating cancer by eliminating actively proliferating malignant cells.
Career Highlights
Kyung-Joo Lee's expertise in chemistry and pharmacology has positioned him as a vital player in the research and development sector. His work at Chong Kun Dang Pharmaceutical Corporation has led him to be recognized for his contributions to oncological therapies and his commitment to advancing medical science through innovative research.
Collaborations
During his career, Lee has collaborated with esteemed colleagues such as Nam-Song Choi and Young-Hoon Kim, who have also played essential roles in various projects. Their combined efforts have enriched the research environment and advanced the development of effective pharmaceutical solutions.
Conclusion
In summary, Kyung-Joo Lee exemplifies the spirit of innovation in the pharmaceutical industry. His patent on benzophenone thiazole derivatives represents a significant advancement in oncology, showcasing the potential of novel chemical compounds to thwart cancer cell proliferation. Lee’s work at Chong Kun Dang Pharmaceutical Corporation, paired with his collaborations, underscores the importance of teamwork in the pursuit of groundbreaking medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile